lucitanib,nivolumab
clovis,bms,servier
['lio-1', 'opdivo', 'lucitanib', '$clvs', 'clovis']
$clvs new data presented at #esmo virtual congress 2020 highlight breadth and potential of clovis oncology products and pipeline: initial data from the phase 1b part of the lio-1 trial of lucitanib combined with opdivo 
To invest is not to bet, you can try but maybe you'll cry. My opinion is not your decision, choose an option at your own risk.